Evaxion A (EVAX) Change in Cash (2020 - 2022)
Evaxion A's (EVAX) quarterly Change in Cash came in at -$37.6 million in Q2 2022, down 299.92% YoY from $18.8 million in Q2 2021, and down 219.66% on a QoQ basis from $31.4 million in Q1 2022.
Evaxion A (EVAX) Change in Cash (2020 - 2022) Analysis & Trends
Evaxion A (EVAX) has 3 years of Change in Cash data on file, last reported at -$37.6 million in Q2 2022.
- Quarterly Change in Cash fell 299.92% year-over-year to -$37.6 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $18.8 million (down 63.78% YoY) and the FY2025 annual result came in at $15.8 million, up 8379.03% from the prior year.
- Change in Cash fell to -$37.6 million in Q2 2022, from $31.4 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $31.4 million in Q1 2022 to a low of -$37.6 million in Q2 2022.
- A 3-year average of $7.3 million and a median of $7.1 million in 2020 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2021 — Change in Cash jumped 462.31% — and 2022, when it slumped 299.92%.
- Tracing EVAX's Change in Cash over 3 years: stood at -$1.7 million in 2020, then jumped by 462.31% to $6.2 million in 2021, then slumped by 708.04% to -$37.6 million in 2022.
- The last three Change in Cash figures came in at -$37.6 million (Q2 2022), $31.4 million (Q1 2022), and $6.2 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -37.58 Mn |
| Mar 31, 2022 | 31.41 Mn |
| Sep 30, 2021 | 6.18 Mn |
| Jun 30, 2021 | 18.80 Mn |
| Mar 31, 2021 | 26.96 Mn |
| Sep 30, 2020 | -1.71 Mn |
| Jun 30, 2020 | 7.88 Mn |
| Mar 31, 2020 | 6.35 Mn |